Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New way of examining lymph tissue detects hidden melanoma


A new study shows that molecular analysis of a very small tissue sample can identify hidden melanoma metastases in lymph nodes. The presence of melanoma in the lymph nodes is the single most important factor in determining a patient’s prognosis and is a key factor in determining a patient’s course of treatment.

Published in the October 1 issue of the Journal of Clinical Oncology, the study is the first to use such a thin section of archival paraffin-embedded tissue and show that a specific set of molecular characteristics indicates the presence of melanoma in the lymph nodes – even among patients whose lymph nodes appear cancer-free using standard techniques. By using a small tissue section, pathologists spare more of the whole specimen, which is needed for additional pathology tests.

"Our findings show that by performing molecular analysis on a very small piece of tissue, we can quickly and accurately identify previously undetectable metastases, and provide a more accurate prognosis for patients," said Dr. Dave S.B. Hoon, director of the Department of Molecular Oncology at the John Wayne Cancer Institute in Santa Monica, California, and senior author of the study. "Providing a more accurate prognosis can inform decisions on when and how to treat patients, and could ultimately improve our ability to care for patients with melanoma."

Dr. Hoon and his team designed a molecular test to detect the presence of four melanoma-associated proteins, or "markers," in lymph node tissue. They obtained archived tissue samples from 77 patients. Standard tests revealed that 37 of the samples contained melanoma, indicating a poor prognosis. However, using the new molecular analysis, researchers showed that the lymph nodes of 25 percent of the 40 patients whose nodes were thought to be cancer-free actually contained two or more of the melanoma-associated markers.

Researchers then observed all patients for nearly five years to determine if there was any correlation between the number or type of melanoma markers and patients’ clinical outcomes. They found that patients with two or more of the markers were more than twice as likely to develop a recurrence of their disease than patients whose lymph node samples presented zero or one marker, and were nearly five-times as likely to die as a result of recurrence.

"Our study is the first to show that patients who express these specific melanoma markers are much more likely to have a poorer outcome, which has wide-ranging implications for the type and extent of treatment that they receive," said Dr. Hoon. "In addition, we are able to identify these patients using a previously-archived tissue sample, sparing the remainder of the valuable whole tissue specimen for other tests."

Dr. Hoon and his colleagues are in the process of enrolling patients in larger clinical trials that will examine the use of these and other markers to better detect melanoma in the lymph nodes, which could dramatically improve the accuracy of diagnosis and identify patients who would benefit from stringent monitoring and preventive therapy.

"Prediction of Disease Outcome in Melanoma Patients by Molecular Analysis of Paraffin-Embedded Sentinel Lymph Nodes." Christine Kuo, M.D. et al.; John Wayne Cancer Institute, St. John’s Health Center, Santa Monica, CA. Vol 21, No 19 (October 1), 2003, pp 3566-3572.

The Journal of Clinical Oncology is the semi-monthly peer-reviewed journal of the American Society of Clinical Oncology (ASCO), the world’s leading professional society representing physicians who treat people with cancer.


For the full text of any JCO article call 703-519-1423 or 212-584-5014.
The JCO News Digest is also distributed via email. Please let us know if you would like to be added to our email distribution list.

Carrie Housman | EurekAlert!

More articles from Health and Medicine:

nachricht Advanced analysis of brain structure shape may track progression to Alzheimer's disease
26.10.2016 | Massachusetts General Hospital

nachricht Indian roadside refuse fires produce toxic rainbow
26.10.2016 | Duke University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

How nanoscience will improve our health and lives in the coming years

27.10.2016 | Materials Sciences

OU-led team discovers rare, newborn tri-star system using ALMA

27.10.2016 | Physics and Astronomy

'Neighbor maps' reveal the genome's 3-D shape

27.10.2016 | Life Sciences

More VideoLinks >>>